Effect of Post-exercise Nutrition on Glycemia in Women (PEN)

May 30, 2023 updated by: Jenna Gillen, University of Toronto

Influence of Post-exercise Greek Yogurt on 24 h Glycemic Control in Women With Overweight/Obesity

The purpose of this study is to assess whether post-exercise Greek yogurt following a single session of aerobic exercise improves metabolic and musculoskeletal health in women with overweight/obesity.

Study Overview

Detailed Description

Following the acquisition of informed consent, eligibility to participate in the study will be determined using questionnaires. Participants will undergo baseline testing at our laboratory at the University of Toronto to determine cardiorespiratory fitness, body composition and undergo exercise familiarization.

Eligible participants will be assigned, in a random order, to two metabolic trials approximately 4 weeks apart that involve 4 days of controlled diet and exercise. Each trial takes place over 4 days, but participants are not required to come to the laboratory on all days. The two trials involve: 1) Exercise + Greek Yogurt (GY) 2) Exercise + a carbohydrate-based study supplement (SS).

During the 4 day trials, participants consume controlled diets and the study supplements (GY and SS). On 1 of these days participants will perform exercise in our lab followed by the consumption of GY or SS. Various outcomes will be measured throughout the trial, including glycemic control (via continuous glucose monitoring), fat oxidation, appetite and health outcomes in blood samples.

Throughout the duration of the study, participants will be asked to maintain their habitual diet and physical activity patterns, and maintain their current body weight.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 18-45 yrs
  • BMI ≥27 kg/m2
  • Elevated waist circumference (≥88 cm)
  • ≤2 structured exercise sessions/week
  • Weight stable (within ± 2kg for at least 6 months)
  • Experiencing regular natural menstrual cycles
  • Non-smoker

Exclusion Criteria:

  • Allergy to dairy foods
  • Diagnosed lactose intolerance or an aversion to foods provided during the study (e.g., post-exercise snacks)
  • Previous history of cardiovascular or metabolic disease
  • The use of medication for managing blood glucose or lipid metabolism
  • Current use of oral contraceptives or use within the last 3 months
  • Irregular menstrual cycles (<21 days or >35 days)
  • Pregnant or lactating
  • Recreational tobacco or cannabis use
  • Inability to perform the study exercise protocols
  • Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-intensity interval exercise and post-exercise Greek yogurt (HIIE+GY)
Participants will consume greek yogurt following a single session of exercise
Following 2 days of controlled diet, participants will consume greek yogurt following high-intensity interval exercise
Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast
Active Comparator: High-intensity interval exercise and post-exercise carbohydrate study supplement (HIIE +SS)
Participants will consume a carbohydrate-based study supplement following a single session of exercise
Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast
Following 2 days of controlled diet, participants will consume a carbohydrate-based study supplement following high-intensity interval exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postprandial glycemia
Time Frame: 24 hour post-exercise
Postprandial glucose exposure assessed using continuous glucose monitoring
24 hour post-exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
24 hours average glucose
Time Frame: 24 hours post-exercise
Average glucose concentration over 24 hours
24 hours post-exercise
Nocturnal glucose
Time Frame: 6-8 hours
Overnight glucose concentration
6-8 hours
Nocturnal glucose
Time Frame: 6-8 hours
Overnight glucose exposure (area under the curve)
6-8 hours
Glycemic variability
Time Frame: 24 hours
Continuous overall net glycemic action (CONGA)
24 hours
Glycemic variability
Time Frame: 24 hours
Standard deviation (SD)
24 hours
Glycemic variability
Time Frame: 24 hours
Coefficient of variation (%CV)
24 hours
Post-exercise fat oxidation
Time Frame: 1, 2 and 3 hours post-exercise
Fat oxidation assessed with indirect calorimetry
1, 2 and 3 hours post-exercise
Fasting glucose concentration
Time Frame: 24 hours post-exercise
Venous blood sampling
24 hours post-exercise
Fasting insulin concentration
Time Frame: 24 hours post-exercise
Venous blood sampling
24 hours post-exercise
Fasting insulin resistance
Time Frame: 24 hours post-exercise
Homeostasis Model Assessment (HOMA2)
24 hours post-exercise
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
Serum concentration of CTX
30, 90, and 180 minutes and 24 hours post-exercise
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
Serum concentration of OPG
30, 90, and 180 minutes and 24 hours post-exercise
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
Serum concentration of RANKL
30, 90, and 180 minutes and 24 hours post-exercise
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
Serum concentration of OC
30, 90, and 180 minutes and 24 hours post-exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jenna Gillen, PhD, University of Toronto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2023

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

April 1, 2024

Study Registration Dates

First Submitted

May 5, 2023

First Submitted That Met QC Criteria

May 16, 2023

First Posted (Actual)

May 25, 2023

Study Record Updates

Last Update Posted (Actual)

June 2, 2023

Last Update Submitted That Met QC Criteria

May 30, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 42756-3

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Greek yogurt

3
Subscribe